Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reassessing genomic targeting of AID.

Literature DB >> 22910380

Reassessing genomic targeting of AID.

Marc A Hogenbirk, Arno Velds, Ron M Kerkhoven, Heinz Jacobs.

Abstract

Mesh：

Substances：

Year: 2012 PMID： 22910380 DOI： 10.1038/ni.2367

Source DB: PubMed Journal: Nat Immunol ISSN： 1529-2908 Impact factor: 25.606

× No keyword cloud information.

10 in total

1. ChIP-Seq: technical considerations for obtaining high-quality data.

Authors: Benjamin L Kidder; Gangqing Hu; Keji Zhao
Journal: Nat Immunol Date: 2011-09-20 Impact factor: 25.606

2. A clustering approach for identification of enriched domains from histone modification ChIP-Seq data.

Authors: Chongzhi Zang; Dustin E Schones; Chen Zeng; Kairong Cui; Keji Zhao; Weiqun Peng
Journal: Bioinformatics Date: 2009-06-08 Impact factor: 6.937

Review 3. Computation for ChIP-seq and RNA-seq studies.

Authors: Shirley Pepke; Barbara Wold; Ali Mortazavi
Journal: Nat Methods Date: 2009-11 Impact factor: 28.547

4. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes.

Authors: Arito Yamane; Wolfgang Resch; Nan Kuo; Stefan Kuchen; Zhiyu Li; Hong-wei Sun; Davide F Robbiani; Kevin McBride; Michel C Nussenzweig; Rafael Casellas
Journal: Nat Immunol Date: 2010-11-28 Impact factor: 25.606

5. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5.

Authors: Rushad Pavri; Anna Gazumyan; Mila Jankovic; Michela Di Virgilio; Isaac Klein; Camilo Ansarah-Sobrinho; Wolfgang Resch; Arito Yamane; Bernardo Reina San-Martin; Vasco Barreto; Thomas J Nieland; David E Root; Rafael Casellas; Michel C Nussenzweig
Journal: Cell Date: 2010-10-01 Impact factor: 41.582

6. The transition between transcriptional initiation and elongation in E. coli is highly variable and often rate limiting.

Authors: Nikos B Reppas; Joseph T Wade; George M Church; Kevin Struhl
Journal: Mol Cell Date: 2006-12-08 Impact factor: 17.970

7. How does multiple testing correction work?

Authors: William S Noble
Journal: Nat Biotechnol Date: 2009-12 Impact factor: 54.908

8. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations.

Authors: Davide F Robbiani; Samuel Bunting; Niklas Feldhahn; Anne Bothmer; Jordi Camps; Stephanie Deroubaix; Kevin M McBride; Isaac A Klein; Gary Stone; Thomas R Eisenreich; Thomas Ried; André Nussenzweig; Michel C Nussenzweig
Journal: Mol Cell Date: 2009-11-25 Impact factor: 17.970

Review 9. ChIP-seq: advantages and challenges of a maturing technology.

Authors: Peter J Park
Journal: Nat Rev Genet Date: 2009-09-08 Impact factor: 53.242

Review 10. Molecular mechanisms of antibody somatic hypermutation.

Authors: Javier M Di Noia; Michael S Neuberger
Journal: Annu Rev Biochem Date: 2007 Impact factor: 23.643

10 in total

7 in total

Reassessing genomic targeting of AID.

1. ChIP-Seq: technical considerations for obtaining high-quality data.

2. A clustering approach for identification of enriched domains from histone modification ChIP-Seq data.

Review 3. Computation for ChIP-seq and RNA-seq studies.

4. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes.

5. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5.

6. The transition between transcriptional initiation and elongation in E. coli is highly variable and often rate limiting.

7. How does multiple testing correction work?

8. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations.

Review 9. ChIP-seq: advantages and challenges of a maturing technology.

Review 10. Molecular mechanisms of antibody somatic hypermutation.

1. Defining chromosomal translocation risks in cancer.

Review 2. Generation and repair of AID-initiated DNA lesions in B lymphocytes.

Review 3. AID and Apobec3G haphazard deamination and mutational diversity.

Review 4. AID in Antibody Diversification: There and Back Again.

Review 5. AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

6. Nbs1 ChIP-Seq Identifies Off-Target DNA Double-Strand Breaks Induced by AID in Activated Splenic B Cells.

Review 7. AIDing Chromatin and Transcription-Coupled Orchestration of Immunoglobulin Class-Switch Recombination.